Seaport Therapeutics, Inc. (SPTX)Healthcare | Biotechnology | Boston, United States | NasdaqGS
18.19 USD
-0.61
(-3.245%) ⇩
(May 29, 2026, 4 p.m.
EDT)
After hours: 18.66 +0.47 (2.584%) ⇧ (May 29, 2026, 5:12 p.m. EDT) |
Hot Take ↕ | May 25, 2026, 3:12 a.m. EDT
The immediate catalyst here is the recent pricing of an upsized IPO, which injected significant capital and pushed the share price up from the lows, creating a temporary pop. However, looking past the initial offering hype, the underlying business presents a severe value trap. The company is burning through cash rapidly, with negative free cash flow and operating cash flow, while holding negative book value and reporting losses on both assets and equity. There is no dividend to provide income, and the lack of any price history since the IPO debut makes assessing a multi-year growth trajectory impossible. While the stock is currently trading near its 52-week highs relative to the post-IPO floor, the fundamental reality is a pre-revenue biotech firm with no earnings power and a balance sheet that requires constant dilution or cash infusion to survive. This is not a buy-and-hold opportunity; it is a speculative gamble on future clinical trials rather than an investment in a profitable enterprise. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 964,576,000 |
| Forward P/E | -7.52 |
| Website | https://www.seaporttx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.052419364 |
| Address1 | 101 Seaport Blvd. |
| Address2 | Floor 12 |
| All Time High | 23.0 |
| All Time Low | 14.85 |
| Ask | 18.94 |
| Ask Size | 1 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 287,930 |
| Average Daily Volume3 Month | 610,473 |
| Average Volume | 610,473 |
| Average Volume10Days | 287,930 |
| Bid | 18.17 |
| Bid Size | 1 |
| Book Value | -11.354 |
| City | Boston |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 18.19 |
| Current Ratio | 17.464 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,778,803,200 |
| Day High | 18.6759 |
| Day Low | 17.84 |
| Display Name | Seaport Therapeutics |
| Ebitda | -85,223,000 |
| Ebitda Margins | 0.0 |
| Eps Current Year | -3.25292 |
| Eps Forward | -2.41956 |
| Eps Trailing Twelve Months | -1.94 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 16.766842 |
| Fifty Day Average Change | 1.4231586 |
| Fifty Day Average Change Percent | 0.08487935 |
| Fifty Two Week Change Percent | -5.2419367 |
| Fifty Two Week High | 23.0 |
| Fifty Two Week High Change | -4.8099995 |
| Fifty Two Week High Change Percent | -0.2091304 |
| Fifty Two Week Low | 14.85 |
| Fifty Two Week Low Change | 3.3400002 |
| Fifty Two Week Low Change Percent | 0.22491583 |
| Fifty Two Week Range | 14.85 - 23.0 |
| First Trade Date Milliseconds | 1,777,642,200,000 |
| Float Shares | 2,892,698 |
| Forward Eps | -2.41956 |
| Forward P E | -7.517896 |
| Free Cashflow | -50,781,500 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 58 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.35388002 |
| Held Percent Institutions | 0.28642 |
| Implied Shares Outstanding | 53,027,817 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-05-01 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform. The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations or hepatotoxicity and other side effects. All therapeutic candidates in development are based on this platform, with research and development activities focused on neuropsychiatric medicines. The company serves clinicians and key opinion leaders in the healthcare and neuropsychiatric medicine sectors. The company was founded in 2024 and is based in Boston, Massachusetts. |
| Long Name | Seaport Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 964,576,000 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_1877598160 |
| Net Income To Common | -74,881,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 996,922,959 |
| Number Of Analyst Opinions | 4 |
| Open | 18.61 |
| Operating Cashflow | -77,942,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | (617) 807-4062 |
| Post Market Change | 0.4699993 |
| Post Market Change Percent | 2.5838335 |
| Post Market Price | 18.66 |
| Post Market Time | 1,780,089,139 |
| Previous Close | 18.8 |
| Price Eps Current Year | -5.5918994 |
| Price Hint | 2 |
| Price To Book | -1.6020786 |
| Profit Margins | 0.0 |
| Quick Ratio | 17.134 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.25 |
| Region | US |
| Regular Market Change | -0.609999 |
| Regular Market Change Percent | -3.24467 |
| Regular Market Day High | 18.6759 |
| Regular Market Day Low | 17.84 |
| Regular Market Day Range | 17.84 - 18.6759 |
| Regular Market Open | 18.61 |
| Regular Market Previous Close | 18.8 |
| Regular Market Price | 18.19 |
| Regular Market Time | 1,780,084,800 |
| Regular Market Volume | 112,112 |
| Return On Assets | -0.189 |
| Return On Equity | -0.28084 |
| Sand P52 Week Change | 0.2794361 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 53,027,817 |
| Shares Percent Shares Out | 0.0275 |
| Shares Short | 1,459,469 |
| Short Name | Seaport Therapeutics, Inc. |
| Short Percent Of Float | 0.028900001 |
| Short Ratio | 1.65 |
| Source Interval | 15 |
| State | MA |
| Symbol | SPTX |
| Target High Price | 42.0 |
| Target Low Price | 30.0 |
| Target Mean Price | 35.5 |
| Target Median Price | 35.0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.94 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 16.766842 |
| Two Hundred Day Average Change | 1.4231586 |
| Two Hundred Day Average Change Percent | 0.08487935 |
| Type Disp | Equity |
| Volume | 112,112 |
| Website | https://www.seaporttx.com |
| Zip | 02,210-2186 |